VERO Biotech Named Top Two Stories of 2020 by Pulmonary Hypertension News
The first person with coronavirus disease 2019 (COVID-19) complicating pulmonary hypertension (PH) has received at-home treatment with inhaled nitric oxide (iNO), delivered through the Genosyl system, according to VERO Biotech, manufacturer of Genosyl. Read more: https://pulmonaryhypertensionnews.com/2020/03/25/covid-19-patient-with-ph-treated-with-ino-via-genosyl-vero-biotech-announces/